Suppr超能文献

左旋咪唑对路易斯安那州牛体内奥斯特他线虫抑制性幼虫成熟阶段(9月)和最低抑制阶段(12月/1月)的疗效。

Efficacy of levamisole against Ostertagia ostertagi in Louisiana cattle during maturation of inhibited larvae (September) and during minimal inhibition (December/January).

作者信息

Williams J C, Knox J W, Marbury K S, Swalley R A, Eddi C S

机构信息

Department of Veterinary Science, Louisiana Agricultural Experiment Station, LSU Agricultural Center, Baton Rouge 70803.

出版信息

Vet Parasitol. 1991 Oct;40(1-2):73-85. doi: 10.1016/0304-4017(91)90084-9.

Abstract

Levamisole (LEV) was tested in four experiments to compare efficacy values against Ostertagia ostertagi when larval maturation was occurring (September), following inhibition and also when populations were expected to be largely adult (winter). A primary objective was to determine the importance of developing fourth-stage larvae (DL4) and inhibited, early fourth-stage larvae (EL4) in replacing adult worms lost through treatment and the effect of this on reduced efficacy against adult worms. Young crossbred beef calves ranging in weight from 150 to 230 kg were used in the first (September 1981), second (September 1983) and third experiments (January 1987). Jersey calves of 110 kg average weight were used in the fourth experiment (December 1988). Calves were randomized to groups according to weight and group sizes ranged from three to five calves. All parasite infections were naturally acquired, but a mixture of nematode third-stage larvae (L3) (22,500 per calf), including 20% Ostertagia ostertagi, was inoculated into Jersey calves of Experiment 4 following a 2 week exposure to natural infection. All LEV treatments were by subcutaneous injection at dosages of 6 and 8 mg kg-1. Treatment with ivermectin was used only in Experiment 3 as an efficacy reference. All calves were killed at 8-10 days after treatment. The efficacy of LEV against all developmental stages of Ostertagia ostertagi was consistently low in all experiments and a dose-dependent response was not evident. Large numbers of all Ostertagia ostertagi developmental stages were present in non-treated calves in both September experiments. Percent reduction of adults, DL4 and EL4 at the 6 mg kg-1 and 8 mg kg-1 dosages, respectively, were adults, 51.7 and 23.6 (1981), 8.7 and 51.3 (1983); DL4 40.3 and 13.2 (1981), 37.9 and 33.1 (1983); EL4, 19.6 and 0 (1981), 59.6 and 42.9 (1983). Smaller numbers of Ostertagia ostertagi were present in winter experiments and adult worms greatly outnumbered larval stages. Percent reductions of adults, DL4 and EL4, respectively, were (1987) LEV 6 mg kg-1, 40.2, 0 and 0; ivermectin 200 micrograms kg-1, 98.7, 97.7 and 100.0; (1988) LEV 6 mg kg-1, 62.4, 100.0 and 100.0; LEV 8 mg kg-1, 49.1 65.0 and 74.1. Too few larval stages were present in the latter experiment for valid efficacy values.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

在四项试验中对左旋咪唑(LEV)进行了测试,以比较其在幼虫成熟阶段(9月)、抑制期以及预计虫群大多为成虫期(冬季)时对奥斯特他线虫的药效值。一个主要目的是确定发育中的第四期幼虫(DL4)和受抑制的早期第四期幼虫(EL4)在替代因治疗而损失的成虫方面的重要性,以及这对降低对成虫药效的影响。体重在150至230千克之间的年轻杂交肉牛犊用于第一次试验(1981年9月)、第二次试验(1983年9月)和第三次试验(1987年1月)。平均体重110千克的泽西牛犊用于第四次试验(1988年12月)。犊牛按体重随机分组,每组数量为3至5头。所有寄生虫感染均为自然感染,但在试验4的泽西牛犊经过2周自然感染暴露后,给每头接种了包括20%奥斯特他线虫在内的混合线虫第三期幼虫(L3)(每头22,500条)。所有LEV处理均通过皮下注射,剂量为6和8毫克/千克。仅在试验3中使用伊维菌素治疗作为药效参考。所有犊牛在治疗后8至10天宰杀。在所有试验中,LEV对奥斯特他线虫所有发育阶段的药效始终较低,且未观察到明显的剂量依赖性反应。在9月的两次试验中,未治疗的犊牛体内存在大量奥斯特他线虫的所有发育阶段。在6毫克/千克和8毫克/千克剂量下,成虫、DL4和EL4的减少百分比分别为:成虫,1981年为51.7和23.6,1983年为8.7和51.3;DL4,1981年为40.3和13.2,1983年为37.9和33.1;EL4,1981年为19.6和0,1983年为59.6和42.9。冬季试验中奥斯特他线虫数量较少,成虫数量大大超过幼虫阶段。1987年,6毫克/千克LEV处理下成虫、DL4和EL4的减少百分比分别为40.2、0和0;200微克/千克伊维菌素处理下分别为98.7、97.7和100.0;1988年,6毫克/千克LEV处理下分别为62.4、100.0和100.0;8毫克/千克LEV处理下分别为49.1、65.0和74.1。后一次试验中幼虫阶段数量过少,无法得出有效的药效值。(摘要截取自400字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验